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Smad (Co-Smad) that lacks the R-Smad conserved SXSJoshua P. Frederick1 and Xiao-Fan Wang
Department of Pharmacology and Cancer Biology motif. Activated heteromeric Smad complexes translo-
cate from the cytoplasm to the nucleus where they areDuke University Medical Center
Durham, North Carolina 27710 able to modulate the transcription of various TGF- tar-
get genes through MH1 (Mad homology domain)-medi-
ated direct contact with Smad binding elements (SBEs)
or indirectly via other transcription factors that bind theThe transforming growth factor- (TGF-) signal is
promoters of TGF- target genes [5, 6].manifest through activated heteromeric Smad com-
The function of an active Smad transcriptional com-plex-mediated transcriptional modulation of target
plex is affected both positively and negatively throughgenes that translates into diverse, context-specific bi-
interaction with other cofactor, coactivator, and core-ologic effects, such as the potent TGF--initiated cyto-
pressor molecules. Significantly, the binding of many ofstatic program. The TGF- pathway is effectively an-
these Smad-interacting molecules has been mapped totagonized through the direct binding and subsequent
the MH2 domain of the Smads, e.g., Fast-1, Mixer, AML,repression of activated Smad heteromeric complexes
CBP/p300 TGIF. Some R-Smad cofactors, such as Fast-1by the Ski family of proto-oncoproteins.
and Mixer, have been shown to directly associate with
the R-Smad MH2 (Mad homology 2) hydrophobic corri-
dor via a common motif, the Smad interaction motif (SIM)
The TGF- signaling pathway has an important role in [7]. The hydrophobic protein binding interface within
many developmental and biological processes, and the the MH2 domain of R-Smads represents an important
misregulation of this pathway has pathological conse- protein binding interface that is distinct from the func-
quences in the initiation and progression of various dis- tional R-Smad:Smad4 interface. The binding of multiple
ease states such as in many human cancers. The se- Smad-interacting proteins to closely overlapping re-
creted, negative growth factor TGF- is a member of a gions within the R-Smad hydrophobic corridor leads to
ligand superfamily that initiates its signaling cascade by mutually exclusive binding in certain scenarios. This in
binding its type II Ser/Thr receptor kinase, which in turn turn has functional consequences in the coordination
phosphorylates the corresponding type I receptor ki- of the TGF- signal. Binding of the R-Smad MH2 corridor
nase within its Gly/Ser (GS) region. Subsequently, the by the SARA SBD retains R-Smads in the cytoplasm in
activated type I receptor transduces the TGF- signal an inactive state to assist in receptor recognition and
through specific phosphorylation of serine residues of accessibility, whereas binding of an overlapping region
the C-terminal SXS motif present in the receptor-regu- by nuclear cofactors such as Fast-1 facilitates nuclear
lated Smad (R-Smad) class of the intracellular Smad retention and assists in transcriptional activation [7, 8].
family of effectors. These proteins contain conserved Nuclear import and export of continuously nucleocy-
amino- and carboxy-terminal domains termed Mad ho- toplasmic shuttling of R-Smads 2 and 3 is in part medi-
mology domains 1 and 2, respectively, separated by a ated through direct contact of the hydrophobic corridor
proline-rich linker region. with the nucleoporin CAN/nup214 [4]. Similarly, the bind-
The R-Smads 2 and 3 are specifically phosphorylated ing of some coactivator and corepressor molecules to
by the TGF- and activin type I receptors whereas the the R-Smad hydrophobic corridor is likely mutually ex-
R-Smads 1, 5, and 8 serve as substrates for the bone clusive resulting in cooperation with or repression of
morphogenic protein (BMP) type I receptors. The L45 Smad mediated transcriptional modulation, respec-
loop of the type I receptors interacts with the L3 loop tively. The coordination of activated heteromeric Smad
of the R-Smads and a few distinct amino acids within complex formation, their subcellular localization, asso-
these loops determine type I receptor/R-Smad binding ciation with cofactors and binding to promoter DNA
specificity [1]. The receptor:R-Smad interaction is facili- sequence ultimately results in Smad complex-directed
tated by the intimate binding of the Smad binding do- transcriptional control of TGF- target genes (Figure 1).
main (SBD) of membrane-bound SARA (Smad anchor for The Ski proto-oncoprotein family of corepressors, in-
receptor activation) to three corresponding hydrophobic cluding c-Ski and SnoN, play important roles in both the
patches within the MH2 domain of the highly homolo- tightly controlled repression of Smad-mediated tran-
gous R-Smad2 and R-Smad3 [2, 3]. These hydrophobic scriptional activation in normal cells as well as contribut-
patches on the MH2 domain have been termed the ing to TGF- insensitivity of cells that contain aberrant
R-Smad “hydrophobic corridor” [4]. The R-Smad:SARA levels of Ski proteins. Several recent studies have pro-
interaction keeps inactive, unphosphorylated R-Smad vided important insight into Ski-mediated repression of
monomers in the cytoplasm, yet upon receptor activa- Smad-induced transcriptional activation of TGF- target
tion it facilitates access of the type I receptor to its genes. The structural basis for this repression has begun
substrate. Subsequent to TGF- receptor-mediated to be elucidated through the proposed structural model
phosphorylation, R-Smads 2 and 3 form heteromeric of c-Ski bound to Smad3 [3] and the determination of
complexes with Smad4, a common signaling mediator the crystal structure of c-Ski packaged with Smad4 in
the November issue of Cell [9]. Together these studies
not only contribute to our understanding of c-Ski-medi-1Correspondence: jpf1@duke.edu
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Figure 1. The Formation of a Transcription-
ally Active, Heteromeric Smad Complex
R-Smads are serine phosphorylated by the
TGF- type I receptor at their conserved car-
boxy-terminal SXS motif and subsequently
associate with Co-Smad4, forming a hetero-
meric Smad complex mediated through
the R-Smad:Co-Smad interface. Heteromeric
Smad complexes are then actively translo-
cated from the cytoplasm to the nucleus in
which they either bind DNA directly through
interaction with promoter-contained Smad
binding elements (SBEs) as depicted or indi-
rectly through other DNA binding transcrip-
tion factors. Smad-mediated transcriptional
control of TGF- target genes is affected both
positively and negatively through interaction
with cofactors, such as FAST1, coactivators
such as p300/CBP, and corepressors such as
c-Ski/SnoN. The Smad amino- and carboxy-
terminal Mad Homology (MH) domains 1 and
2, respectively, are separated by a proline-
rich linker region.
ated repression of Smad transactivation activity, as well phosphorylated R-Smad/Smad4 complex compared to
a homotrimeric phosphorylated R-Smad complex. Theas TGF- signaling in general, but also highlight a chal-
lenge in drawing conclusions from structural studies resulting heteromeric complex shares structural similar-
ity with the homotrimeric complex in which the protein-of fragments derived from full-length proteins and the
importance of considering native structural issues in protein interface is mediated by the C-terminal helix-
bundle of the R-Smad packed against the loop-helixcellular biology experiments.
Formation of a Transcriptionally Active, region of Smad4.
Characterizations of identity of which Smads and theHeteromeric Smad Complex
In order to appreciate how Ski corepressors affect a number of Smad molecules that constitute an activated,
oligomeric Smad complex vary. Homomeric or hetero-transcriptionally active heteromeric Smad complex, it is
important to consider what constitutes such a complex meric? Smad4 has been shown to be dispensable for
some TGF-/Smad-mediated transcriptional effects yetin a biologically relevant context. As briefly discussed,
the R-Smad:SARA interaction retains inactive, unphos- clearly is an integral player in transcriptionally active
Smad complexes in normal circumstances. Althoughphorylated R-Smad monomers in the cytoplasm, yet
upon receptor activation aids in the access of the type homomeric R-Smad complexes may be transcriptionally
active in certain scenarios, such a complex has yet toI receptor to its substrate. The serine phosphorylation
of the carboxy terminus of the R-Smad monomers de- be characterized in wild-type, mammalian cells. Dimeric
or trimeric? Although it is possible that the compositioncreases its affinity for SARA binding and increases its
affinity for homotrimeric interaction. The R-Smad homo- of an activated heteromeric R-Smad/Co-Smad complex
could be trimeric (2:1, 1:2) and/or dimeric (1:1), the bio-trimeric interface is mediated through MH2 domain con-
tacts in which the carboxy-terminal helix-bundle region chemical characterization and biological significance of
variously composed heteromeric Smad complexes willof one R-Smad monomer is nestled in the loop-helix
region of an adjacent monomer [19, 10]. The formation have to be further defined in a context specific manner.
For example, it has recently been determined that aof the trimeric complex is significantly enhanced by the
anchoring of the phosphorylated serine residues of one heterotrimeric complex of Smad2 and Smad4 in a 2:1
ratio is able to form on specific elements within the Mix.2R-Smad molecule to a highly conserved p-Ser binding
motif in the L3/B8 loop-strand pocket of an adjoining promoter whereas a heterodimeric complex of Smad3
and Smad4 associates with the Smad binding region ofSmad [19]. Phosphorylated R-Smads subsequently form
an activated heteromeric complex with Smad4. The for- the c-jun promoter [11].
Ski-Mediated Repression of Smadmation of the heteromeric Smad complex in preference
to a homotrimeric complex is possibly driven by the Transcriptional Complexes
Although the constituents of a transcriptionally activeequilibrium of available phosphorylated R-Smads with
an abundance of unphosphorylated Smad4. The driving heteromeric Smad complex is likely defined in a cell-
type, protein binding partner and promoter-specific con-forces involved in the formation of an activated hetero-
meric Smad complex need to be further characterized. text, Ski proteins are exquisitely tailored in an evolution-
ary sense to counteract the TGF- signal. Skis exertIt will be of interest to determine if potential interactions
between the MH1 domain and linker region of full length their ability to antagonize TGF- through a direct, high-
affinity interaction with Smads. This interaction allowsSmads contribute to the formation of a heteromeric
Minireview
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Ski to bind specific DNA sequences such as the SBE for association (Figure 2A). Mutational analysis confirmed
the importance of this portion of the c-Ski:Smad4 interfacesequence, GTCT or its palindrome AGAC. Interestingly,
c-Ski and SnoN interacts with the MH2 domains of for binding in that mutation of c-Ski Trp274 (Trp274Glu)
completely abolished the interaction between c-ski andR-Smads and Smad4 through two distinct regions. c-Ski
contains two conserved R-Smad interaction domains, a Smad4, yet did not affect c-Ski:Smad3 binding.
The binding of the c-Ski I-loop to the Smad4 L3 loopmajor interaction site within the most N-terminal portion
of the proteins and a minor contact site between amino region generates an interface that overlaps with that of
the modeled p-Ser Smad2 MH2:Smad4 MH2 complex.acids 241 and 441. The Smad4 binding domain of c-Ski
is a disparate site in which residues 203–239 of c-Ski have Thus, the c-Ski:Smad4 interaction would lead to the dis-
ruption of the active heteromeric Smad complex. c-Skibeen shown to be critical for c-Ski:Smad4 association [12].
The ability of c-Ski to bind to either R-Smads or Smad4 and the Smad4 MH2 domain form a 1:1 complex in which
the structure of Smad4 is very similar to that of Smad4 inis sufficient to repress TGF--mediated transcriptional
modulation, whereas mutation of both the major R-Smad isolation with the notable exception of subtle conforma-
tional changes in the loop-helix region that is importantand Smad4 binding sites completely abrogates this re-
pressive effect [13, 9]. for R-Smad binding. These differences in the  sandwich,
as well as the steric hindrance that c-Ski docking wouldIn normal cells, c-Ski and SnoN are rapidly degraded
in response to TGF- treatment in a proteasome-depen- create near the L1 and L2 loops of Smad4, establish a
scenario in which Smad4 bound to c-Ski would be unabledent manner, and SnoN levels are ultimately elevated
in a negative-feedback loop to repress the TGF-/Smad to associate with p-Ser Smad2. Indeed, Smad4 Tyr513,
which anchors p-Ser 465 of R-Smad2 in an active hetero-transcriptional signal [14, 15]. The TGF--induced deg-
radation of the cellular Ski proteins is thought to provide meric Smad complex, is hydrogen bonded to Thr271 of
the c-Ski I-loop. Both in vitro and in vivo experiments showa window of opportunity for Smad-mediated transcrip-
tional activation in the absence of these potent core- that the binding of the c-Ski Co-Smad interaction domain
(skiCoSID) and the phosphorylated R-Smad MH2 domainpressor molecules. It has been shown that the TGF-
-induced degradation of SnoN is mediated through to Smad4 are mutually exclusive. Thus, the stable associa-
tion of c-Ski with an active, heteromeric Smad complexR-Smad-dependent recruitment of the E3 ligases ana-
phase-promoting complex (APC) and Smurf2 to SnoN defined by an intact R-Smad:Co-Smad4 interface would
be impossible.[16–18]. In the case of TGF--induced, APC-directed
SnoN destruction, three regions of SnoN are essential: It is formally possible that c-Ski could bind simultane-
ously to Smad4 and R-Smads through distinct Smad inter-(1) the N-terminal R-Smad interaction domain, (2) the
conserved APC/CDH1 binding destruction box (D-box), action domains, resulting in a c-Ski/R-Smad/Smad4 com-
plex. Herein lies one of the major points of the Wu et al.and (3) critical lysine residues (Lys440, 446, and 449)
that are required for ubiquitination [16, 17]. It should be study in terms of biological relevance. Although c-Ski may
be present in a complex containing both phosphorylatednoted that TGF--induced degradation of SnoN is more
efficient compared to that of c-Ski. This could be be- R-Smad and Smad4, the presence of c-Ski disrupts the
R-Smad:Co-Smad interface of an active heteromeric com-cause the region of SnoN that was shown to be ubiquiti-
nated in response to TGF- is not well conserved in plex. A recent study has demonstrated by analytical ultra-
centrifugation that the N-terminal R-Smad interaction do-c-Ski. However, this does not preclude the possibility
that c-Ski is degraded in a similar fashion since ubiquiti- main (skiRSID) of c-Ski (residues 16–40) preferentially
binds a homotrimeric, Smad3 MH2 domain complex com-nation of nonconserved lysines within c-Ski may still
occur. Interestingly, v-Ski does not contain the N-ter- pared to a monomeric molecule [3]. Yet it should be noted
that a Smad3 mutation deficient in homo- or heteromeriza-minal R-Smad interaction domain conserved in SnoN and
c-Ski, and thus may not be degraded in response to TGF- tion has been reported to mediate SnoN degradation as
efficiently as wild-type Smad3, suggesting that Smad3-treatment. This may have important consequences in
terms of how dysregulated v-Ski expression or degrada- mediated degradation of c-Ski may not require Smad ho-
motrimerization [16]. Although the 24 amino acid c-Skition-deficient Ski/SnoN constitutively repress Smad-medi-
ated transcription, and thus the more global effects of RSID peptide may be capable of binding an active hetero-
meric Smad complex, it is necessary to consider whatTGF- signaling such as the presumably tumor-sup-
pressive TGF- antiproliferative program. effect the c-Ski CoSID would exert on such a complex,
that is, disruption of the R-Smad:Co-Smad interface. InThe question of how c-Ski is such an effective repressor
of Smad-mediated transcriptional activation and thus the fact, Shi and coworkers show that the N-terminal R-Smad
interaction domain of c-Ski (skiRSID) disrupts a SmadTGF- pathway in general has begun to be addressed at
the structural level in the recent study by Shi and cowork- heteromeric complex via competitive binding for R-Smads
in the same manner that the skiCoSID was shown to com-ers [9]. The crystal structure of the Smad4 binding region
of c-Ski (residues 219–312) packaged with the MH2 do- pete for binding to Smad4.
It is important to note that the deletion of the Ski RSIDmain of Smad4 reveals a protein:protein interface com-
prised of a highly conserved interaction loop (I-loop) of (which inhibits R-Smad but not Smad4 binding) or a W274E
point mutation within the I-loop of the Ski CoSID (whichc-Ski and the L3 loop region of Smad4. Buttressed by a
bound zinc atom at its base, the adjacent c-Ski I-loop prevents interaction with Smad4 but not R-Smad) does
not eliminate the ability of c-Ski to repress TGF--inducedinserts an aromatic Trp274 residue into a five-residue hy-
drophobic pocket on Smad4, of which three residues are transcriptional activity. In order to inhibit its ability to antag-
onize the TGF- signal, c-Ski must be unable to interactSmad4 specific, that creates an impressive network of van
der Waals interactions that is most likely the driving force with both Smad4 and R-Smad [9]. In contrast, the viral
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Figure 2. c-Ski-Mediated Transcriptional Re-
pression of Heteromeric Smad Complexes
(A) The conserved interaction loop (I-Loop)
of c-Ski forms an interface with the L3 loop
region of Smad4. The structure of a Ski-
Smad4 complex is schematically shown here,
with Smad4 (magenta) and Ski (cyan) repre-
sented as a surface contour and a coil, re-
spectively. A few important interface residues
of c-Ski, invariant among Ski family members,
are highlighted in yellow and magnified in the
inlaid box. The region of Smad4 that binds
R-Smads is indicated by the green oval. Fig-
ure preparation assisted by Y. Shi.
(B) c-Ski acts as a disrupting bridge between
the R-Smad:Co-Smad interface via R-Smad
association through its amino terminus and
Smad4 binding through its I-loop, as indi-
cated within the dashed box. c-Ski interaction
with R-Smads and Smad4 exerts transcrip-
tional repression through disruption of the
R-Smad:Co-Smad interface, binding occlu-
sion of a subset of Smad cofactor/coactiva-
tors, and the c-Ski-mediated recruitment of
other repressor molecules. A generic, tran-
scriptionally active heteromeric Smad com-
plex is depicted on the left, whereas a c-Ski-
repressed complex is represented on the
right.
counterpart to this family of cellular proteins, v-Ski, is fully viral replication, whereas one of the functions of c-Ski in
a normal cell is to repress the activity of a heteromericable to repress Smad-induced transcriptional activation
and induce cellular transformation despite the fact that Smad complex in a tightly regulated manner. It is possible
that the putative disrupting bridge that c-Ski forms be-it contains only the Smad4 binding region that is highly
conserved in residues essential for Smad4 interaction. If c- tween R-Smads and Co-Smads in the nucleus plays an
important role in the regulated coordination of TGF- sig-Ski and its homolog c-SnoN can repress Smad-mediated
transactivation through either the conserved R-Smad or naling. One can imagine that the putative R-Smad:c-Ski:
Co-Smad depicted in Figure 2B is important for bothSmad4 binding domains, then why would these proteins
contain both domains? Although c-Ski/SnoN can disrupt maximum repression of a transcriptionally active hetero-
meric Smad complex as well as R-Smad mediated deg-a heteromeric Smad complex through either their R-Smad
or Smad4 interaction domains, it seems likely that the radation of c-Ski/SnoN that would allow an initial win-
dow of opportunity for Smad-mediated transcriptionalpresence of the two interaction domains serves some
purpose that is not functionally relevant from the point of activation of TGF- target genes. The absence of the
R-Smad interaction domain in v-Ski may prevent TGF-view of an avian Sloan-Kettering retrovirus, the virus from
which v-Ski was isolated. v-Ski might have evolved in part induced degradation resulting in an unregulated and
constant repression of the TGF- signal.to constitutively counteract the TGF- signal and thus
TGF--mediated growth inhibition in order to maximize The ability of c-Ski to repress TGF-induced transacti-
Minireview
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19. Wu, J.-W., Hu, M., Chai, J., Seoane, J., Huse, M., Li, C., Rigotti,vation is likely manifested through multiple conse-
D.J., Kyin, S., Muir, T.W., Fairman, R., et al. (2001). Mol. Cell 8,quences of c-Ski interactions with Smads via its distinct
1277–1289.Smad interaction domain. After TGF- induces degrada-
tion of cellular Skis and Smad-mediated transcriptional
activation of target genes, coordinated increases of Ski
levels in normal cells would result in: (1) disruption of
the R-Smad:Co Smad interface; (2) possible occlusion of
the R-Smad MH2 hydrophobic corridor thus preventing
access of other hydrophobic corridor-interacting pro-
teins; and (3) Ski-mediated recruitment of other core-
pressor molecules such as N-CoR and HDACs (Figure
2B). Cancer cells with elevated levels of Ski proteins are
insensitive to TGF- signaling due to the maintained
state of repression that misregulated Skis exert on
Smads. This repression of Smad activity may contribute
to Ski-induced cellular transformation since misregu-
lated and/or continuous nuclear Ski expression could
effectively trap Smads in the nucleus thereby “freezing”
them in an inactive state.
Due to the technical challenges that the inherently
flexible nature of the interdomain sequence in Smads
pose, only specific domains of a Smad transcriptional
complex and an inactive Smad:Ski complex have been
visualized. There would be much to gain from the crystal-
lization of a transcriptionally active heteromeric Smad
complex comprised of full length Smad protein bound
to appropriate DNA sequences and subsequent charac-
terization of how the composition and structure of this
Smad complex is altered by the binding of full-length
c-Ski.
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